Disposition of mitoxantrone in patients

This publication has 8 references indexed in Scilit:

• Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantrone
  Journal of Chromatography B: Biomedical Sciences and Applications, 1982
• Pharmacology of mitoxantrone in cancer patients
  Cancer Chemotherapy and Pharmacology, 1982
• Clinical kinetics of 1,4-dihydroxy-5,8-bis [[2- [(2-hydroxyethyl)amino ]ethyl] amino]-9,10-anthracenedione
  Clinical Pharmacology & Therapeutics, 1982
• High performance liquid chromatography of a new anticancer drug, ADCA--physicochemical properties and pharmacokinetics
  Life Sciences, 1981
• Clinical analysis for the anti-neoplastic agent 1,4-dihydroxy-5,8-bis{{2-[(2-hydroxyethyl)amino]ethyl}amino} 9,10-anthracenedione dihydrochloride (NSC 301739) in plasma
  Journal of Chromatography B: Biomedical Sciences and Applications, 1981
• Phase I clinical trial of mitoxantrone: A new anthracenedione anticancer drug
  Cancer Chemotherapy and Pharmacology, 1980
• An HPLC Method for the Quantitative Determination of 1,4-Dihydroxy-5,8 Bis [[2-[(2-Hydroxyethyl) Amino] Ethyl] Amino] 9,10 - Anthracenedione (DHAQ, Lederle Labs CL232 315, NCS 301739) in Serum
  Journal of Liquid Chromatography, 1980
• Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer Drugs
  New England Journal of Medicine, 1978